Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination
Plasmodium vivax remains an important cause of morbidity and mortality across the Americas, Horn of Africa, East and South East Asia. Control of transmission has been hampered by emergence of chloroquine resistan...
Source: Malaria Journal - Category: Infectious Diseases Authors: Thomas C. S. Martin and Joseph M. Vinetz Tags: Opinion Source Type: research
More News: African Health | Infectious Diseases | Malaria | Malaria Vaccine | Parasitology | Vaccines